Examining the place of the female condom in india's family planning program aqualitative investigation of the attitudes, opinions of key stakeholders in Pune, India.
Contraception
Family planning
Female condoms
Reproductive health
Women-initiated contraception
Journal
BMC public health
ISSN: 1471-2458
Titre abrégé: BMC Public Health
Pays: England
ID NLM: 100968562
Informations de publication
Date de publication:
05 09 2022
05 09 2022
Historique:
received:
28
10
2021
accepted:
24
08
2022
entrez:
5
9
2022
pubmed:
6
9
2022
medline:
9
9
2022
Statut:
epublish
Résumé
With overpopulation contributing to the depletion of planetary resources, the high rates of unintended pregnancies in India are a cause for concern. Despite the free supply of contraception options within India's national family planning initiatives, women are generally offered hormonal options as temporary spacing methods. However, female condoms, a much neglected but potent woman initiated, non-hormonal multipurpose prevention device, are yet to be considered for inclusion in India's contraceptive cafeteria. Thus, we aim to examine the place of female condoms among the contraceptive options, by analysing the perceptions of key stakeholders regarding its advantages and disadvantages, along with their opinions on how female condoms should be promoted. We used purposive sampling to recruit and interview potential users and dispensers of the female condom. The interview participants visited or worked at family planning clinics in Pune at Smt. Kashibai Navale Medical College and General Hospital (SKNMC-GH), its urban and rural outreach clinics, and at Saheli (a non-governmental organisation for female sex workers). We conducted semi-structured interviews and coded our data inductively. We interviewed 5 rural women, 20 urban women (including 10 female sex workers), 5 male partners of female sex workers, and 5 family planning healthcare providers. Nearly half (12/25) of the women we interviewed, said that they were eager to use female condoms in the future. Many participants perceived female condoms to be an instrument to empower women to be in control of their sexual and reproductive lives (15/35), and that it provided user comfort and confidence (4/35). Their perceived disadvantages are that they are relatively more expensive (6/35), users have limited experience (9/35), and women who buy or use them may be stigmatised and feel embarrassed (4/35). Yet, nearly three-quarters of potential users (21/30) and most healthcare providers (4/5), were confident that female condoms could become popular following extensive promotional campaigns, interventions to improve availability and access, and initiatives to enhance the knowledge of female users. Female condoms have garnered support from both users and dispensers and have the potential to be widely adopted in India if family planning initiatives which increase awareness, knowledge, and access are systematically undertaken as with other contraceptive options.
Sections du résumé
BACKGROUND
With overpopulation contributing to the depletion of planetary resources, the high rates of unintended pregnancies in India are a cause for concern. Despite the free supply of contraception options within India's national family planning initiatives, women are generally offered hormonal options as temporary spacing methods. However, female condoms, a much neglected but potent woman initiated, non-hormonal multipurpose prevention device, are yet to be considered for inclusion in India's contraceptive cafeteria. Thus, we aim to examine the place of female condoms among the contraceptive options, by analysing the perceptions of key stakeholders regarding its advantages and disadvantages, along with their opinions on how female condoms should be promoted.
METHODS
We used purposive sampling to recruit and interview potential users and dispensers of the female condom. The interview participants visited or worked at family planning clinics in Pune at Smt. Kashibai Navale Medical College and General Hospital (SKNMC-GH), its urban and rural outreach clinics, and at Saheli (a non-governmental organisation for female sex workers). We conducted semi-structured interviews and coded our data inductively.
RESULTS
We interviewed 5 rural women, 20 urban women (including 10 female sex workers), 5 male partners of female sex workers, and 5 family planning healthcare providers. Nearly half (12/25) of the women we interviewed, said that they were eager to use female condoms in the future. Many participants perceived female condoms to be an instrument to empower women to be in control of their sexual and reproductive lives (15/35), and that it provided user comfort and confidence (4/35). Their perceived disadvantages are that they are relatively more expensive (6/35), users have limited experience (9/35), and women who buy or use them may be stigmatised and feel embarrassed (4/35). Yet, nearly three-quarters of potential users (21/30) and most healthcare providers (4/5), were confident that female condoms could become popular following extensive promotional campaigns, interventions to improve availability and access, and initiatives to enhance the knowledge of female users.
CONCLUSIONS
Female condoms have garnered support from both users and dispensers and have the potential to be widely adopted in India if family planning initiatives which increase awareness, knowledge, and access are systematically undertaken as with other contraceptive options.
Identifiants
pubmed: 36064344
doi: 10.1186/s12889-022-14054-3
pii: 10.1186/s12889-022-14054-3
pmc: PMC9442954
doi:
Substances chimiques
Contraceptive Agents
0
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
1675Informations de copyright
© 2022. The Author(s).
Références
Sex Reprod Healthc. 2019 Mar;19:15-23
pubmed: 30928130
Reprod Health. 2019 Dec 12;16(1):178
pubmed: 31831034
J Obstet Gynaecol India. 2011 Dec;61(6):626-34
pubmed: 23204678
Indian J Public Health. 2020 Jan-Mar;64(1):32-38
pubmed: 32189680
PLoS One. 2020 Feb 25;15(2):e0229333
pubmed: 32097433
Reprod Health Matters. 2006 Nov;14(28):23-31
pubmed: 17101419
Reprod Health. 2019 Dec 3;16(1):175
pubmed: 31796046
Open Access J Contracept. 2018 Jan 05;9:1-10
pubmed: 29440936
Womens Health Issues. 2015 Jul-Aug;25(4):366-76
pubmed: 26048756
Indian J Med Res. 2014 Nov;140 Suppl:S152-6
pubmed: 25673537
Asian J Res Soc Sci Humanit. 2015;5(6):18-33
pubmed: 29430437
Res Soc Work Pract. 2009 Sep 1;19(5):503-518
pubmed: 20976022
Reprod Health Matters. 2010 May;18(35):119-28
pubmed: 20541090
PLoS One. 2021 Mar 10;16(3):e0246530
pubmed: 33690636
PLoS One. 2020 Aug 13;15(8):e0236984
pubmed: 32790677
Asian Surv. 1984;24(7):736-58
pubmed: 11616645
BMC Public Health. 2020 Mar 12;20(1):319
pubmed: 32164652
BMC Public Health. 2016 Jan 28;16:85
pubmed: 26822805
Lancet Glob Health. 2017 Mar;5(3):e350-e358
pubmed: 28193400
AIDS Behav. 2013 Jul;17(6):2194-201
pubmed: 23212854
Best Pract Res Clin Obstet Gynaecol. 2020 Jul;66:55-67
pubmed: 32007451
Contraception. 2005 Nov;72(5):366-71
pubmed: 16246664
Indian J Med Res. 2014 Nov;140 Suppl:S147-51
pubmed: 25673536
J Womens Health (Larchmt). 2013 Jan;22(1):26-36
pubmed: 23276188
J Health Psychol. 2018 Feb;23(2):218-228
pubmed: 29250996
Lancet Glob Health. 2018 Jan;6(1):e16-e17
pubmed: 29241603